Average Co-Inventor Count = 4.78
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Allergan, Inc. (120 from 2,285 patents)
2. Allergan Sales, Inc. (3 from 228 patents)
3. Allergen Sales, Inc. (1 from 4 patents)
4. Bhat, Smita (0 patent)
5. Garst, Michael E. (0 patent)
6. Beard, Richard L. (0 patent)
7. Chow, Ken (0 patent)
8. Donello, John E. (0 patent)
9. Sinha, Santosh C. (0 patent)
124 patents:
1. 9849113 - Methods of treating α adrenergic mediated conditions
2. 9623006 - Methods of treating α adrenergic mediated conditions
3. 9522150 - Alpha adrenergic receptor modulators
4. 9402912 - Antibiotic conjugates directly linked with steroid drugs
5. 9402913 - Cyclosporine A steroid conjugates
6. 9371296 - Bicyclic 1,3,4-oxadiazole derivatives as sphingosine-1-phosphate receptors' modulators
7. 9199989 - N—(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors
8. 9120784 - 1,3,4-oxadiazoles-2-thio azetidine derivatives as sphingosine-1 phosphate receptors modulators
9. 9108993 - Pyrazole derivatives as sphingosine 1-phosphate (S1P) receptor modulators
10. 9079864 - Modulators of S1P receptors
11. 9062030 - Pyrazole azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulators
12. 9040532 - Alpha adrenergic receptor modulators
13. 9034910 - Methods of treating alpha adrenergic mediated conditions
14. 9034896 - [object Object]
15. 9000016 - 1,3,4-Oxadiazoles-2-thio derivatives as sphingosine-1 phosphate receptors modulators